Timing of anti–PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma
Titel:
Timing of anti–PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma
Auteur:
Hirayama, Alexandre V. Kimble, Erik L. Wright, Jocelyn H. Fiorenza, Salvatore Gauthier, Jordan Voutsinas, Jenna M. Wu, Qian Yeung, Cecilia C. S. Gazeau, Nicolas Pender, Barbara S. Kirchmeier, Delaney R. Torkelson, Aiko Chutnik, Abigail N. Cassaday, Ryan D. Chapuis, Aude G. Green, Damian J. Kiem, Hans-Peter Milano, Filippo Shadman, Mazyar Till, Brian G. Riddell, Stanley R. Maloney, David G. Turtle, Cameron J.